Banced Corp’s St Jude Medical STJ Stock Holding History

Banced Corp’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-3,950	Closed	-$258K	–	210
2014 Q1	$258K	Buy	3,950 +409	+12%	+$26.6K	0.27%	155
2013 Q4	$219K	Buy	+3,541	New	+$205K	0.22%	164

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IIS

Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Banced Corp's STJ Position: Q2 2014 in Review

Banced Corp sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 3,950 shares — an estimated $258K sold.

Banced Corp first reported a position in STJ in Q4 2013 and held it in 2 quarters. The position peaked at $258K in Q1 2014. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

Banced Corp reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
Banced Corp sold 3,950 St Jude Medical shares in Q2 2014, an estimated $258K.
Banced Corp first reported a position in St Jude Medical in Q4 2013 and held it in 2 quarters.
Banced Corp's St Jude Medical position peaked at $258K in Q1 2014.
555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on Banced Corp's 13F filing for Q2 2014, filed 8 Jul 2014.